0000899243-20-010009.txt : 20200402 0000899243-20-010009.hdr.sgml : 20200402 20200402192949 ACCESSION NUMBER: 0000899243-20-010009 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200401 FILED AS OF DATE: 20200402 DATE AS OF CHANGE: 20200402 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sukhija Remy CENTRAL INDEX KEY: 0001806949 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33277 FILM NUMBER: 20771089 MAIL ADDRESS: STREET 1: 48 PHEASANT HILL ROAD CITY: PRINCETON STATE: NJ ZIP: 08540 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MADRIGAL PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001157601 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 BARR HARBOR DRIVE, SUITE 400 CITY: WEST CONSHOHOCKEN STATE: PA ZIP: 19428 BUSINESS PHONE: 404-380-9263 MAIL ADDRESS: STREET 1: 200 BARR HARBOR DRIVE, SUITE 400 CITY: WEST CONSHOHOCKEN STATE: PA ZIP: 19428 FORMER COMPANY: FORMER CONFORMED NAME: SYNTA PHARMACEUTICALS CORP DATE OF NAME CHANGE: 20010815 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2020-04-01 0 0001157601 MADRIGAL PHARMACEUTICALS, INC. MDGL 0001806949 Sukhija Remy FOUR TOWER BRIDGE 200 BARR HARBOR DRIVE, SUITE 200 WEST CONSHOHOCKEN PA 19428 0 1 0 0 SVP and Chief Comm'l Officer Stock Option (Right to Buy) 60.26 2020-04-01 2030-04-01 Common Stock 60000 D The option vests as to 25% of the underlying Common Stock on the first anniversary of the date of grant (April 1, 2021) and thereafter as to 6.25% of the underlying Common Stock on the last day of each successive three-month period, provided the Reporting Person continues in service with the Issuer on each such date. /s/ Brian Lynch, as Attorney- In-Fact for Remy Sukhija 2020-04-02